Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over $2bn as part of the company’s broader portfolio ...

Teleflex (TFX) has agreed to sell its acute care, interventional urology and OEM businesses to two buyers for a combined $2.03 billion in cash, subject to adjustments. Intersurgical will acquire the ...

Needham analysts said Teleflex’s inability to secure a price above the low end of their expectations could reflect “the continued poor performance of UroLift.” ...

Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...

After announcing plans to split up the company near the top of this year, Teleflex said it has found new homes for its businesses spanning acute care, urology and medical hardware manufacturing. Two ...

Teleflex’s TFX Interventional Urology portfolio is well positioned for sustained growth, led by UroLift’s expanding global footprint and strong clinical differentiation. Supported by favorable ...

Wondering if Teleflex is a beaten down opportunity or a value trap at today’s price? Let us walk through what the numbers are really saying about the stock. After sliding 3.8% over the last week, ...

In the last three months, 5 analysts have published ratings on Teleflex (NYSE:TFX), offering a diverse range of perspectives from bullish to bearish. The following table provides a quick overview of ...

The what, where, when, why and how was known, but the who behind a new, roughly 150-employee medical device research facility being built on former VF Outlet Center property in Wyomissing was the big ...

The latest price target for Teleflex (NYSE:TFX) was reported by Truist Securities on May 5, 2025. The analyst firm set a price target for $137.00 expecting TFX to rise to within 12 months (a possible ...

New, independent, publicly traded company (NewCo) consisting of Teleflex’s Urology, Acute Care, and OEM businesses. RemainCo will consist of Teleflex’s Vascular Access, Interventional, and Surgical ...